申请人:AstraZeneca AB
公开号:US07842803B2
公开(公告)日:2010-11-30
Nicotinic acetylcholine receptor ligands of Formula I
wherein X, n, R1 and R2 are as described in the specification, diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing, and methods for using the same.
烟碱性乙酰胆碱受体配体I式,其中X,n,R1和R2如规范所述,包括对映异构体,对映体,药学上可接受的盐,制备方法,含有药物的制剂组合物以及使用它们的方法。